Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)

被引：0

作者：

Patil, S.

Figlin, R. A.

Hutson, T. E.

Michaelson, M. D.

Negrier, S.

Kim, S. T.

Huang, X.

Motzer, R. J.

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] City Hope Comprehens Canc Ctr, Duarte, CA USA

[3] Texas Oncol PA, Baylor Sammons Canc Ctr, Dallas, TX USA

[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[5] Ctr Leon Berard, F-69373 Lyon, France

[6] Pfizer Oncol, La Jolla, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5042

引用

页数：2